Skip to main content

Drug Interactions between sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine and toripalimab

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

SARS-CoV-2 mRNA (tozinameran-tris-sucrose) vaccine toripalimab

Applies to: sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine and toripalimab

If you are currently being treated or are going to begin treatment with toripalimab, you should let your doctor know before receiving SARS-CoV-2 mRNA (tozinameran-tris-sucrose) vaccine. Toripalimab can cause potentially serious immune-related side effects and receiving SARS-CoV-2 mRNA (tozinameran-tris-sucrose) vaccine during treatment with toripalimab may increase that risk. Your healthcare provider may already be aware of the risks but has determined that this is the best course of treatment for you and is monitoring you closely for any potential complications. You should seek immediate medical attention if you experience severe diarrhea; serious skin reactions such as a widespread rash, peeling skin, or blisters; signs of liver problems like yellowing of your skin or eyes, or pain on the right side of your abdomen; lung issues such as shortness of breath, chest pain, coughing, or extreme fatigue; kidney problems like difficulty urinating, sudden weight gain, or swelling in your feet, ankles, or legs; or thyroid and other endocrine issues such as fatigue, sluggishness, constipation, depression, hoarseness, or unexplained weight gain.

Switch to professional interaction data

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer